Skip to main navigation Skip to search Skip to main content

SUPPRESSION OF RECURRENT HERPES LABIALIS WITH VALACYCLOVIR

Project: Research

Project Details

StatusFinished
Effective start/end date11/1/9703/25/02

Funding

  • Glaxo Wellcome Incorporated: $67,010.40